Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DATURA Trial: Intensified TB Regimen in HIV-associated Severe Immune Suppression
NCT04738812Phase 3Completed
- Sponsor
- ANRS
- Start
- Apr 2022
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of rifampicin, isoniazid in Tuberculosis (TB), sponsored by ANRS. Started Apr 2022; status: completed.
02
Drugs
rifampicinisoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT04738812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04738812.